To address the significance of AREG as a target for CRC therapy, we examined the mRNA expression and supernatant protein levels of EGFR ligands from CRC cell lines (HCT116, HT29, LoVo, WiDr, CoLo201, and LS180) under 3DC conditions. This evidence concerns the gene AREG and colorectal carcinoma.